Fig. 3From: Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trialProportions in each group of infants showing < 1 faecal deposition/day (white), 1–3 faecal depositions/day (grey) or > 3 faecal depositions/dayBack to article page